info:eu-repo/semantics/article
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment
Fecha
2021-06Registro en:
Miceli, Diego Daniel; Zelarayán, Gabriela S; García, Jorge D; Fernández, Viviana; Ferraris, Sergio; Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment; SAGE Publications; Journal of Feline Medicine and Surgery Open Reports; 7; 2; 6-2021; 1-7
2055-1169
2055-1169
CONICET Digital
CONICET
Autor
Miceli, Diego Daniel
Zelarayán, Gabriela S
García, Jorge D
Fernández, Viviana
Ferraris, Sergio
Resumen
A 7-year-old spayed female domestic shorthair cat weighing 5kg was referred with polyuria, polydipsia, lethargy, abdominal distension and dermatologic abnormalities. Diabetes mellitus was diagnosed and treatment was started with a diet for diabetic cats and insulin glargine (1IU q12h SC). Hyperadrenocorticism (HAC) was suspected and diagnosed based on clinical signs, increased urinary cortisol:creatinine ratio, lack of suppression on low-dose dexamethasone suppression test and abdominal ultrasonography demonstrating bilateral adrenal enlargement. Oral cabergoline (10μg/kg every other day) was initiated. After the second administration of cabergoline, the cat suffered from clinical hypoglycemia and no longer required insulin. One month after insulin withdrawal, blood work and urine analysis results showed normoglycemia, a normal serum fructosamine concentration (244μmol/l) and normal urine analysis without glycosuria. Diabetic remission persisted until its death 7 months later. In addition, cabergoline treatment was associated with improvement in clinical signs such as lethargy, seborrhea, alopecia and abdominal distension.